Biomedical subjects
Mark Ratner
Publications and source records attributed to Mark Ratner.
Looking for solid ground along the Critical Path.
Explore the source record for details and available documents.
Stress-biased rearrangements and preyield behavior in glasses.
On the basis of a physical picture of a glass as a mosaic of mesoscopic clusters differing in their yield characteristics, we propose a model for the preyield behavior in glassy materials; the model describes the stress-strain relationship at different strain rates in terms of one reduced variable. A test using experimental data for polycarbonate materials at different rates and temperatures appears favorable for the model. The model may be used to interpolate and extrapolate limited experimental data, and also provides a practical means to assess dynamic heterogeneities within polymeric glasses. When applied at different temperatures, the model gives insight into the dependence of the excitation energies on temperature (glassformer fragility) in the glassy state.
A turbulent year at the agency.
Explore the source record for details and available documents.
Complement inhibitors finally find orphan niches.
Explore the source record for details and available documents.
Molecular electronics: charged with manipulation.
Explore the source record for details and available documents.
Maturing biotechs turn to pharma's markets.
Explore the source record for details and available documents.
Syrrx acquisition signals maturation of structure-based discovery.
Explore the source record for details and available documents.
Earlier stage biotechs attract partners.
Explore the source record for details and available documents.
New IGF drug stirs competition in growth factor segment.
Explore the source record for details and available documents.
Industry shrugs off NIH consulting ban.
Explore the source record for details and available documents.
FDA pharmacogenomics guidance sends clear message to industry.
Explore the source record for details and available documents.
Neuroimaging heats up.
Explore the source record for details and available documents.
As products enter clinic...scientists shown the door.
Explore the source record for details and available documents.
Genentech discloses safety concerns over Avastin.
Explore the source record for details and available documents.
Novel initiative seeks genetic causes of diabetes risk.
Explore the source record for details and available documents.